| Posted: October 24, 2008 |
Chinese nanotechnology symposium discussed nanomedicine for cancer treatment |
|
(Nanowerk News) Recent years have witnessed the rapid development of China's nano-science and technology with widespread influence. In January 2008, a proposal to convene a Sino-US symposium on nano-medicine and nano-biology was jointly made by Director of the US National Institutes of Health Dr. Elias Zerhouni, Director of the US National Cancer Institute Dr. John E. Niederhuber and Director of the National Institute of Environmental Health Sciences Dr. Samuel Wilson.
|
|
To integrate outstanding research forces in China and carry out exchanges with scholars around the world, in particular the U.S., the Xiangshan Science Conferences (XSSC) held a symposium on nanotechnology and nano-drugs for cancer treatment from October 21-23, in Beijing.
|
|
Studies of nanomedicine and nano-drugs for cancer treatment are an emerging field that takes full advantage of expertise and research approaches from such academic disciplines as nanotechnology, biology, chemistry, physics, medicine, pharmaceutics and public health. No single discipline can deal with the new field characterized with strong interdisciplinary and comprehensive studies. It is both a topic at the cutting-edge of science development and an important social issue closely related to people's health and environment, offering unlimited opportunities for innovation.
|
|
The meeting was focused on nano-drugs and nano-technology for cancer treatment, environmental health of nanotechnology and its safety, and the strategy and policy for nanotechnology development.
|
